交叉上市是改善盈利质量的灵丹妙药吗?中国H股和B股公司的案例
Is cross-listing a panacea for improving earnings quality? The case of H- and B-share firms in China
International Review of Financial Analysis · 2022
被引 12
ABS 3
- Shimin Chen
- Serene Xu Ni 通讯
- Özgür Arslan‐Ayaydin
- James Thewissen
交叉上市盈利质量公司治理中国资本市场